Every one of those 1 sits in a single category, market-trends. Avanos Medical, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 3 original sources each against 4.7 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Leonardo DRS, Inc.
Every one of those 1 sits in a single category, market-trends. Avanos Medical, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 3 original sources each against 4.7 for the same window. At 5, the average consequence score sits below the same-window beat average of 5.6. Leonardo DRS, Inc. appears in 1 tracked Healthcare story from February 26, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Leonardo DRS, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Avanos Medical and Clarivate Plc reported Q4 2025 results highlighting a shift toward high-margin specialized medical devices and AI-driven life sciences analytics. Despite macroeconomic headwinds, these entities demonstrate a sector-wide pivot toward operational efficiency and data-centric healthcare solutions.
Leonardo DRS, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.